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Virulence of emerging community-associated methi-
cillin-resistant Staphylococcus aureus (CA-MRSA)
and other highly pathogenic S. aureus strains
depends on their production of phenol-soluble
modulin (PSM) peptide toxins, which combine the
capacities to attract and lyse neutrophils. The molec-
ular basis of PSM-stimulated neutrophil recruitment
has remained unclear. Here, we demonstrate that
the human formyl peptide receptor 2 (FPR2/ALX),
which has previously been implicated in control of
endogenous inflammatory processes, senses PSMs
at nanomolar concentrations and initiates proinflam-
matory neutrophil responses to CA-MRSA. Specific
blocking of FPR2/ALX or deletion of PSM genes in
CA-MRSA severely diminished neutrophil detection
of CA-MRSA. Furthermore, a specific inhibitor of
FPR2/ALX and of its functional mouse counterpart
blocked PSM-mediated leukocyte infiltration in vivo
in a mouse model. Thus, the innate immune system
uses a distinct FPR2/ALX-dependent mechanism to
specifically sense bacterial peptide toxins and detect
highly virulent bacterial pathogens. FPR2/ALX repre-
sents an attractive target for new anti-infective or
anti-inflammatory strategies.
INTRODUCTION
Staphylococcus aureus is a frequent constituent of the human
microflora and also a major cause of severe infectious diseases
ranging from skin and wound infections to life-threatening
disseminated infections (Foster, 2004). Whereas methicillin-Cell Hresistant S. aureus (MRSA) strains, which are particularly
refractory to antibiotic treatment, used to be restricted to
hospital settings without colonizing healthy individuals, new
highly pathogenic MRSA clones such as USA300 (LAC) and
USA400 (MW2) are increasingly emerging in the population
(Chambers and Deleo, 2009; Saı¨d-Salim et al., 2003). These
community-associated (CA-) MRSA represent a major threat
even for healthy persons and demand new efforts to under-
stand, prevent, and treat S. aureus infections. CA-MRSA
combine extraordinary virulence, resistance, and spreading
capacities and are causing alarming epidemics in various parts
of the world (Chambers and Deleo, 2009; Kahl and Peters,
2007). Severe infections by CA-MRSA and other highly patho-
genic S. aureus strains are associated with massive influx
and subsequent lysis of neutrophils with concomitant tissue
damage (Wang et al., 2007; Bubeck Wardenburg et al., 2007).
A number of virulence factors, including a-hemolysin and the
phage-encoded Panton-Valentine toxin, appear to contribute
to the virulence of CA-MRSA (Diep et al., 2008; Bubeck War-
denburg et al., 2007; Kahl and Peters, 2007). In addition, we
have recently shown that virulence of CA-MRSA depends crit-
ically on secretion of high amounts of phenol-soluble modulin
(PSM) peptide toxins. The seven core genome-encoded
S. aureus PSMs, one of which is the d-toxin, a long-known
virulence factor, and the PSM-mec produced by a minority of
hospital-acquired MRSA (HA-MRSA) strains have lengths of
20–44 amino acids and a-helical, amphipathic secondary struc-
tures (Wang et al., 2007; Queck et al., 2009). They destroy
neutrophils very efficiently, most probably by disrupting the
neutrophil membranes. In contrast, less-pathogenic S. aureus
such as most HA-MRSA produce only very low PSM levels
(Wang et al., 2007). Whereas the PSMs are cytolytic at micro-
molar concentrations, they are also chemoattractants for
neutrophils and contribute to massive leukocyte infiltration
(Wang et al., 2007; Queck et al., 2009); the molecular basis of
this latter phenomenon has remained unclear.ost & Microbe 7, 463–473, June 17, 2010 ª2010 Elsevier Inc. 463
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tions, with a high capacity to eliminate invading microbes and
activate additional host defense mechanisms. Neutrophils
migrate to sites of infection in response to chemotactic stimuli,
which are recognized by G protein-coupled receptors (GPCRs).
In addition to endogenous mediators such as chemokines,
neutrophils can directly respond to specific bacterial molecules.
Leukocytes recognize such ‘‘pathogen-associated molecular
patterns’’ (PAMPs), e.g., via Toll-like receptors (TLRs) (Uematsu
and Akira, 2006) or via certain GPCRs such as the formyl peptide
receptor 1 (FPR1) (Le et al., 2002; Fu et al., 2006). Though TLRs
can activate host cells, only the latter type of receptor can elicit
chemotactic migration. FPR1 recognizes formylated bacterial
peptides, which represent a hallmark of bacterial infections
because only bacterial cells start protein biosynthesis with a for-
mylated methionine, whereas the cytoplasmic ribosomes of
human cells use an unmodified methionine residue. Accordingly,
formylated peptides have been shown to represent major
chemotactic PAMPs (Du¨rr et al., 2006; Mader et al., 2010).
S. aureus produces a specific inhibitor of the human FPR1, the
chemotaxis-inhibitory protein of S. aureus (CHIPS), to block for-
mylated peptide recognition (de Haas et al., 2004). However, it
has also become clear that bacteria produce further chemotactic
molecules of an unknown nature (Du¨rr et al., 2006).
S. aureus also secretes a specific inhibitor for the FPR1-related
formyl peptide receptor 2 (FPR2/ALX; initially denoted formyl-
peptide receptor-like 1, FPRL1) of human neutrophils, the
FPR2/ALX-inhibitory protein (FLIPr) (Prat et al., 2006). The
reasons for FLIPr secretion by S. aureus have remained myste-
rious and have pointed toward a previously unknown role of
FPR2/ALX in S. aureus infections. Whereas it is clear that FPR1
plays an important role in antibacterial host defense, FPR2/ALX
has only residual affinity for bacterial formylated peptides and
has hardly been implicated in pathogen recognition (Murphy
et al., 1992). Instead, FPR2/ALX has been associated with
chronic inflammatory and degenerative diseases such as athero-
sclerosis and Alzheimer’s disease because it responds to
a variety of amyloidogenic peptides (e.g., serum amyloid A, the
b-amyloid Ab1–42 peptide, and the prion protein fragment
PrP106–126) and other endogenous ligands (Su et al., 1999; Cui
et al., 2002; Fu et al., 2006; Ye et al., 2009). Moreover, FPR2/
ALX senses anti-inflammatory agonists such as the lipid lipoxin
A4, endogenous annexin 1-derived peptides, and synthetic
peptide compounds and has also been referred to as receptor
for lipoxin A4 and aspirin-triggered lipoxins (ALX) (Perretti et al.,
2002; Hecht et al., 2009). Nevertheless, the major functions of
FPR2/ALX and the second human FPR1 ortholog, FPR3 that
binds e.g., an N terminally acetylated endogenous peptide
(Migeotte et al., 2005), have remained elusive. FPR-like receptors
are highly diverse in the various mammalian species, indicating
that they are subjected to strong selection pressures (Gao
et al., 1998; Fu et al., 2006; Ye et al., 2009). In addition to different
substrate specificities, the numbers of FPR paralogs vary widely
between species, with seven to eight paralogs in mice compared
to three in humans, which represents a major obstacle for
studying the role of FPR-like receptors in animal models.
Because staphylococcal PSM peptides have previously
been shown to attract neutrophils (Wang et al., 2007; Queck
et al., 2009), we studied the recognition of these molecules by464 Cell Host & Microbe 7, 463–473, June 17, 2010 ª2010 Elsevier Inreceptors of the human FPR family and found the most potent
PSMs to be active at nanomolar concentrations. We demon-
strate that the activity of PSMs does not necessarily depend
on N-terminal formylation and identify FPR2/ALX as the major
receptor for all seven PSMs. Moreover, FPR2/ALX represents
the dominant receptor mediating neutrophil chemotaxis
in response to CA-MRSA, whereas FPR2/ALX is not involved in
the cytotoxic activity of PSMs. These data suggest that the
immune system has developed FPR2/ALX for the detection of
PSM-like virulence factors and indicate a critical role of FPR2/
ALX in innate immunity.RESULTS
Formylated and Nonformylated PSMs Induce Ca2+ Influx
in Human Neutrophils, which Cannot Be Blocked by the
FPR1 Inhibitor CHIPS
S. aureus PSMs have been shown to attract neutrophils, but
structure-function relationships of PSMs with regard to their
chemotactic potential are poorly defined (Wang et al., 2007).
We found PSMa3, the most active of the PSMs, to attract human
neutrophils at nanomolar concentrations (Figures 1A and 1B).
The decrease of chemotaxis at PSMa3 concentrations > 100
nM reflects the activation of neutrophils by high amounts of
GPCR ligands leading to halt of migration (Christophe et al.,
2001) and causing the typical bell-shaped dose-response curve
(Figure 1A). PSMa3 also elicited intracellular calcium ion flux in
neutrophils, which is known to accompany chemotactic migra-
tion (Hartt et al., 1999; Kalmar and Van Dyke, 1994) and can be
measured very sensitively. In contrast, a PSM variant with
scrambled amino acid sequence had no such activity
(Figure S1 available online). Because PSMs usually retain their
N-terminal formyl-groups during secretion (Wang et al., 2007),
we assumed them to be recognized by the human FPR1. Unex-
pectedly, even the nonformylated PSMs, which are produced
under certain environmental conditions depending on the
varying activity of S. aureus peptide deformylase (Somerville
et al., 2003), elicited chemotaxis and Ca2+ ion flux in neutrophils,
albeit at lower concentrations, as the formylated peptides
(Figure 1B). Moreover, the FPR1-inhibitory protein CHIPS
blocked neutrophil response to the synthetic control ligand
fMLF but had no impact on the activity of formylated or nonfor-
mylated PSMs (Figure 1C), which was another indication that
a receptor different from FPR1 is responsible for the proinflam-
matory neutrophil responses to PSMs.PSMs Are Specifically Detected by FPR2/ALX
We confirmed that PSMs are recognized by a G protein-coupled
receptor, as pertussis toxin (PTX), a general antagonist of this
type of receptor, blocked the calcium flux-inducing activities of
representative formylated or nonformylated PSMs (Figure 1C).
Of note, we found that FLIPr, a specific inhibitor of the FPR1
paralog FPR2/ALX, leads to almost complete inhibition of
neutrophil response to both the formylated and nonformylated
PSMs, suggesting that these peptide toxins represent a new
class of FPR2/ALX ligands. Control experiments with the
synthetic FPR2/ALX ligand MMK1 confirmed the specificity of
FLIPr (Figure 1C). Similar results were also obtained when thec.
Figure 1. Formylated and Nonformylated PSM Peptides Elicit Chemotaxis and Calcium Ion Fluxes in Human Neutrophils
(A) PSMa3 stimulates chemotaxis in human neutrophils at nanomolar concentrations with a typical bell-shaped dose-response curve.
(B) Both formylated and nonformylated core genome-encoded PSMs (PSMa1–4, PSMb1 and 2, d-toxin) and PSM-mec induce chemotaxis and chemotaxis-asso-
ciated calcium fluxes in human neutrophils (values normalized to 1 mM).
(C) Neutrophil stimulation by PSMs is sensitive to pertussis toxin and the FPR2/ALX-specific inhibitor FLIPr, but not the FPR1-specific inhibitor CHIPS. fMLF and
MMK1 are synthetic control ligands of FPR1 and FPR2/ALX, respectively.
Data represent means ± SEM of at least three independent experiments. *p < 0.05; **p < 0.005; ***p < 0.001 versus lowest peptide concentration (A) or no inhi-
bition (C). All values were significant versus buffer control in (B) (p < 0.05 or lower). d, d-toxin; fl, fluorescence.
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taxis (data not shown).
In order to further evaluate the role of FPR2/ALX in recognizing
PSM peptides, we analyzed the response to PSMs of HL60 cells
stably transfected with the human FPR1, FPR2/ALX, or FPR3
receptors. Whereas untransfected HL60 cells were unrespon-
sive (data not shown), the FPR1- and FPR2/ALX-transfectedCell Hcells responded to the corresponding control ligands fMLF and
MMK1, respectively, as expected (Figure 2A). All eight formy-
lated PSMs activated FPR2/ALX-transfected cells very effi-
ciently and, depending on the individual peptide, led only to
residual activation of FPR1- or FPR3-transfected cells. Similar
results were obtained with the corresponding nonformylated
PSMs. Dose-response curves of representative PSMs revealedost & Microbe 7, 463–473, June 17, 2010 ª2010 Elsevier Inc. 465
Figure 2. PSMs Specifically Activate and Bind to FPR2/ALX
(A) PSMs stimulate profound calcium fluxes in FPR2/ALX-transfected cells, but not in FPR1 or FPR3-transfected cells. Untransfected HL60 cells exhibited no
significant responses (mean fluorescence values below 1, data not shown). fMLF and MMK1 are synthetic control ligands of FPR1 and FPR2/ALX, respectively.
(B) Dose-response curves for Ca2+ fluxes induced by formylated PSMa3, b2, and d-toxin in FPR2/ALX-transfected HL60 or neutrophils.
(C) 5-carboxytetramethylrhodamin-labeled PSMs bind specifically to FPR2/ALX-transfected HL60 cells. Maximum detected binding to FPR2/ALX-transfected
cells was defined as 100%.
(D) PSMs prevent binding of a FPR2/ALX-specific phycoerythrin-labeled monoclonal antibody (aFPR2) from FPR2/ALX-transfected HL60 cells in a dose-depen-
dent manner. Fluorescence of samples with the phycoerythrin-labeled Isotypecontrol was defined as the maximally achievable inhibition of binding (100% inhi-
bition).
(E) PSMa3 displaces the synthetic 125I-labeld FPR2/ALX ligand WKYMVm from transiently FPR2/ALX-transfected cells. Unlabeled FPR2/ALX ligand CKb8-1 was
used as a positive control.
Data represent mean ± SEM of at least three independent experiments. *p < 0.05; ***p < 0.001 versus untransfected cells (A and C) or versus no peptide (D).
d, d-toxin.
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Table 1. Potencies of PSM Peptides
PSM Peptide
pEC50
a
FPR2/ALX-Transfected HL60
Human
Neutrophils
PSMa3, formylated 8.67 ± 0.29 7.61 ± 0.06
PSMa3, nonformylated 6.59 ± 0.20 5.19 ± 0.24
d-toxin, formylated 7.37 ± 0.17 7.59 ± 0.05
d-toxin, nonformylated 6.32 ± 0.21 5.20 ± 0.14
PSMb2, formylated 6.41 ± 0.36 5.61 ± 0.26
The calcium ion flux-inducing capacities of representative formylated and
nonformylated PSMs are expressed as pEC50 (negative logarithm of half-
maximal effective concentration).
a Data represent means ± SD of at least three independent experiments.
pEC50 values were determined by nonlinear regression analysis of dose-
response curves (11–18 points) generated using GraphPad Prism 4.
A pEC50 value of nonformylated PSMb2 could not be determined, as
the peptide reached a cytolytic concentration before the maximal
calcium ion flux-inducing capacity was achieved.
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lated PSMa3 and d-toxin (Figure 2B) and the other a PSMs
(data not shown). pEC50 (negative logarithm of half-maximal
effective concentration) values of formylated PSMs reached
8.67 (PSMa3), 7.37 (d-toxin), or 6.47 (PSMb2) (Table 1). These
values were considerably lower for nonformylated peptides,
thereby confirming that the formyl groups are not essential but
have a considerable impact on PSM activities. Neutrophils re-
vealed similar or somewhat lower potencies for PSMs as
FPR2/ALX-transfected HL60 (Figure 2B and Table 1). Thus, for-
mylated PSM a peptides are among the most potent naturally
occurring FPR2/ALX peptide ligands, which have reported
pEC50 values between 4.60 and 9.00 (Ye et al., 2009).
Direct binding of representative PSMs to FPR2/ALX was
confirmed by three different approaches. (1) PSM peptides
C terminally labeled with the fluorescent dye 5-carboxytetrame-
thylrhodamin revealed only residual binding to untransfected or
FPR1-transfected HL60 but bound strongly to FPR2/ALX-trans-
fected cells and neutrophils (Figures 2C and S2). (2) PSM
peptides prevented binding of the FPR2-specific monoclonal
antibody #304405 to FPR2-transfected cells (Figure 2D). (3)
PSMa3 displaced the 125I-labeled synthetic FPR2/ALX ligand
WKYMVm (Elagoz et al., 2004; Christophe et al., 2001) from
FPR2/ALX-transfected cells (Figure 2E). From the latter experi-
ment, we calculated pIC50 and Ki values for PSMa3 of 7.3 and
13.3 nM, respectively. Taken together, these data confirm that
FPR2/ALX is the major receptor on human neutrophils binding
and recognizing S. aureus PSM peptides, whereas FPR1 and
FPR3 play only minor roles in recognizing PSM peptides.
FPR2/ALX Does Not Affect the Ability of PSMs
to Lyse Leukocytes
PSM peptides destroy leukocytes at micromolar concentrations,
most probably by membrane disruption (Wang et al., 2007).
However, it has remained unknown whether PSMs use a receptor
on target cells to exert these cytotoxic activities. When release of
cytoplasmic lactate dehydrogenase was monitored as a measure
for PSM-mediated cytolysis, there were no notable differences in
susceptibility of untransfected or FPR1-, FPR2/ALX-, or FPR3-
transfected HL60 (Figure S3). Moreover, FLIPr had no consider-
able impact on PSM-mediated disruption of human neutro-
phils, indicating that PSMs lyse leukocytes independently of
FPR2/ALX.
PSMs Induce Ca2+ Influx in Mouse Leukocytes, which
Can Be Specifically Blocked by an Inhibitor of Human
FPR2/ALX or Its Mouse Counterpart(s)
MMK1 and PSMs also induced calcium fluxes in mouse neutro-
phils (Figure 3A), which is in agreement with our previous finding
that expression of PSM peptides contributes significantly to
neutrophil recruitment by CA-MRSA in a mouse local infection
model (Wang et al., 2007). Thus, mice probably also use FPR-
like receptor(s) to sense PSM-like peptide toxins. However,
mice have a different set of FPR paralogs with seven to eight
members, and it has remained unclear how many and which of
these represent(s) the mouse ortholog(s) of human FPR2/ALX
(Migeotte et al., 2006; Ye et al., 2009). FLIPr did not interfere
with PSM-mediated activation of mouse neutrophils (data not
shown) and is probably highly human specific, as previouslyCell Hdescribed for CHIPS (Prat et al., 2006; de Haas et al., 2004).
However, we noted that the synthetic peptide WRW4, an inhib-
itor of human FPR2/ALX and of at least one mouse FPR paralog
(Fpr-rs2) (Karlsson et al., 2006; Onnheim et al., 2008), had
a potent antagonistic effect on mouse neutrophil stimulation by
MMK1 and PSMs, whereas fMLF-mediated stimulation was
not affected (Figure 3A).
In order to evaluate the impact of FPR-like receptors on PSM-
mediated leukocyte influx in vivo, we used two different mouse
models. (1) Injection of PSMs-producing S. aureus USA300
into the mouse peritoneum caused a considerable increase in
peritoneal neutrophil numbers (Figure 3B). When WRW4 was in-
jected prior to infection, the influx was inhibited, indicating that
the majority of the leukocyte-recruiting activity was dependent
on the mouse counterpart(s) of FPR2/ALX. (2) The capacity of
synthetic PSMs to recruit leukocytes in a mouse air pouch
model, which has been shown to monitor 1.5- to 3-fold increased
leukocyte influxes upon local injection of chemoattractants into
the air pouch (Perretti et al., 2002; Devosse et al., 2009), was
evaluated. Injection of PSMa2, which was the most potent
PSM peptide toward mouse neutrophils (data not shown), led
to strong influx of leukocytes (Figure 3C). However, when
WRW4 was injected into the air pouch prior to PSMa2, the influx
of leukocytes was blocked. In contrast, a scrambled variant of
WRW4 did not inhibit leukocyte influx into air pouches in
response to PSMs (Figure 3C). These data confirm that PSMs
are potent neutrophil attractants and that FPR2/ALX or its func-
tional mouse ortholog(s) are crucial for neutrophils to migrate
toward PSMs in vitro and in vivo.
FPR2/ALX Mediates Very Strong Neutrophil Responses
to CA-MRSA, but Not to HA-MRSA
We have recently described that CHIPS can block most of the
chemotactic activity of neutrophils toward culture supernatants
from the S. aureus laboratory strain RN4220, demonstrating
that formylated peptides represent major neutrophil chemoat-
tractants of this hardly pathogenic strain (Du¨rr et al., 2006).
In contrast, we noted that CHIPS had no significant impact on
neutrophil calcium fluxes induced by culture supernatants fromost & Microbe 7, 463–473, June 17, 2010 ª2010 Elsevier Inc. 467
Figure 3. In Vitro and In Vivo Inhibition of PSM-Mediated Neutrophil Activation and Mobilization in Mice by WRW4
(A) WRW4 blocks calcium fluxes in response to MMK1 and PSMs, but not to fMLF in mouse neutrophils.
(B) Intraperitoneal challenge of mice with S. aureus USA300 induces granulocyte infiltration, which can be blocked by WRW4. Granulocytes were identified by
Gr1+ staining.
(C) PSMa2 leads to leukocyte infiltration into mouse air pouches, and this process can be blocked by WRW4, but not by its scrambled congener wwrw3.
Data represent means ± SEM of at least three independent experiments (A), five to eight independent experiments with the same number of mice per group (B),
or four independent experiments with two to three mice per group (C). *p < 0.05; **p < 0.005; ***p < 0.001. ns, not significantly different as calculated by Student’s
t test (A and B) or Mann-Whitney U test (C).
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than FPR1 is responsible for neutrophil recognition of CA-
MRSA. Of note, CA-MRSA supernatants had about 100-fold
stronger proinflammatory activities compared to the HA-MRSA
strains COL, Mu50, and N315, which corresponds to the extraor-
dinary virulence of CA-MRSA (Wang et al., 2007) (Figure 4C). The
potent neutrophil activation by CA-MRSA was clearly mediated468 Cell Host & Microbe 7, 463–473, June 17, 2010 ª2010 Elsevier Inby PSMs, as deletion of the psma gene cluster encoding the
four most potent PSMs that together constitute the vast majority
of the proinflammatory PSM activity produced by CA-MRSA
(Wang et al., 2007) abrogated most of the neutrophil response
(Figures 5A and 5B). Production of the remaining PSMs in this
mutant has been shown to be unaltered (Wang et al., 2007;
Queck et al., 2008), but their comparatively low expression andc.
Figure 4. FPR2/ALX Initiates Exuberant Proinflammatory Neutrophil Responses to PSMs in CA-MRSA Culture Supernatants
(A and B) Calcium flux stimulated by CA-MRSA culture supernatants is FPR2/ALX dependent in neutrophils (A) and receptor-transfected HL60 cells (B). Untrans-
fected HL60 cells exhibited no significant responses (mean fluorescence values below 1, data not shown).
(C) FPR2/ALX-transfected HL60 cells respond exuberantly to CA-MRSA (USA300, USA400) but only moderately to HA-MRSA (COL, Mu50, N315), whereas
FPR1-mediated responses differ only slightly between CA-MRSA and HA-MRSA.
(D) FLIPr inhibits USA300-stimulated neutrophil chemotaxis and IL-8 release.
The indicated S. aureus wild-type (WT) or PSM gene deletion mutants (Da, Db, or Dd) were used in (A)–(D). USA400 supernatants yielded similar results as shown
for USA300 in (A), (B), and (D) (data not shown). Data represent means ± SEM of at least three independent experiments. **p < 0.005; ***p < 0.001 versus no
inhibition (A and D) or untransfected HL60 (B).
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tion to the FPR2/ALX-dependent stimulatory capacity of CA-
MRSA. Moreover, the strong calcium flux-inducing capacity of
CA-MRSA was almost entirely mediated by FPR2/ALX, as FLIPr
inhibited this activity completely and FPR2/ALX-transfected
HL60 responded magnitudes higher than FPR1-transfected
HL60 to CA-MRSA (Figures 5A–5C). In contrast, the two cell lines
responded with similar efficiency to supernatants from the HA-
MRSA strains COL, Mu50, and N315, albeit at moderate levels.
USA300-induced chemotaxis and IL-8 secretion by neutrophils
were also largely FPR2/ALX dependent (Figure 5D). Collectively,
these date indicate that FPR2/ALX has a critical, unrecognized
role in responding to PSM-like peptide toxins and that leuko-
cytes use PSMs as potent proinflammatory signals from CA-
MRSA.
DISCUSSION
Though the FPR1 receptor recognizes a defined microbial
molecular pattern, an N-formylated methionine followed by
hydrophobic amino acids (Fu et al., 2006), it remains unclear
which structural features define an FPR2/ALX ligand. We alignedCell Hthe S. aureus PSM peptides with each other and with further
known FPR2/ALX ligands but were unable to detect a consis-
tently conserved sequence motif (data not shown), suggesting
that distinct properties in the secondary structure define the
affinity of FPR2/ALX ligands. Though the a-helical amphipathic
structure of PSMs has been noted and may play a role in recog-
nition by FPR2/ALX (Wang et al., 2007), more sophisticated tech-
niques such as three-dimensional NMR will be necessary to
elucidate common features of FPR2/ALX ligands. Of note, diffi-
culties in defining common features in a diverse set of ligands
are reminiscent of other pattern recognition receptors such as
the Toll-like receptors (Uematsu and Akira, 2006).
Whereas most of the currently known PAMPs are shared by
microbial commensals and pathogens, recognition of PSMs by
FPR2/ALX offers the possibility for the innate immune system
to distinguish between commensal and highly pathogenic
microbes and to adjust host responses appropriately (Figure 5).
Though nonpeptide PAMPs such as most TLR ligands are largely
invariant, peptidic PAMPs such as the PSMs can probably be
altered more rapidly in structure. Accordingly, TLR receptors
exhibit only moderate interspecies changes (Leulier and Le-
maitre, 2008), whereas FPR-like receptors vary widely betweenost & Microbe 7, 463–473, June 17, 2010 ª2010 Elsevier Inc. 469
Figure 5. Proposed Role of FPR2/ALX-
Mediated Sensing of PSM Peptide Toxins
FPR2/ALX allows neutrophils to distinguish
between S. aureus with low and high virulence
potential by sensing the concentration of PSMs
and causes neutrophil infiltration in response to
highly pathogenic S. aureus. In contrast, FPR1
mediates moderate neutrophil activation in
response to S. aureus irrespective of virulence.
CHIPS and FLIPr are thought to prevent neutrophil
influx during certain stages of human colonization
and infection when it is most critical for the
bacteria to prevent recruitment of leukocytes (de
Haas et al., 2004; Prat et al., 2006).
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specificities (Gao et al., 1998), indicating a particularly strong
evolutionary pressure on this type of receptor. This notion is
further supported by the fact that primate homologs of FPR2/
ALX show the highest interspecies differences in the ligand-
binding extracellular loops, suggesting positive selection of
ligand recognition capacities (Alvarez et al., 1996). Moreover,
mice, cows, pigs, dogs, and cats hardly respond to fMLF, the
most potent ligand of the human FPR1 (Styrt, 1989), whereas
mice prefer formylated peptides with other sequences (South-
gate et al., 2008).
As another result of ongoing co-evolution, many bacterial path-
ogens exhibit remarkable host specificity with highly human-
specific virulence factors such as the chemotaxis inhibitory S.
aureus proteins CHIPS and FLIPr, which are only functional on
FPR1 and FPR2/ALX, respectively, of human leukocytes (de
Haas et al., 2004; Prat et al., 2006). S. aureus appears to employ
these inhibitors for preventing the influx of neutrophils during
certain stages of human colonization and infection when it is
most critical for the bacteria to prevent recruitment of leukocytes
(de Haas et al., 2004; Prat et al., 2006) (Figure 5). Of note, CA-
MRSA have been shown to express the FLIPr gene, albeit under
different conditions as the PSM genes. PSM, but not FLIPr,
production is tightly controlled by the agr quorum-sensing
system, whereas FLIPr is expressed upon contact with neutrophil
granule contents (Palazzolo-Ballance et al., 2008; Queck et al.,
2008). agr turns PSM expression largely off at early stages of
infection, when it may be advantageous for the bacteria to remain
unrecognized by the innate immune system, and FLIPr may help
to inhibit the activity or residual PSM amounts produced even with
inactive agr. S. aureus strains involved in chronic infection often
disable the agr system and thereby PSM production (Shopsin470 Cell Host & Microbe 7, 463–473, June 17, 2010 ª2010 Elsevier Inc.et al., 2008), whereas CA-MRSA strains
are often regarded as less well-adapted
new lineages with dysregulated, exces-
sive toxin production. In concert with other
toxins, PSM peptides appear to be so
effective in destroying neutrophils with
concomitant tissue damage that the
active recruitment of neutrophils via
FPR2/ALX can even provide an advantage
for these emerging pathogens (Diep
and Otto, 2008). Accordingly, CA-MRSAinfections are notorious for extensive tissue destruction, e.g., in
necrotizing pneumonia, necrotizing fasciitis, and sepsis with
Waterhouse-Friedrichsen syndrome (Chambers and Deleo,
2009; Kahl and Peters, 2007). The regulation of peptide deformy-
lase activity, which leads to deformylated PSM peptides with
reduced capacity to stimulate FPR2/ALX in response to bacterial
growth phase and iron availability (Somerville et al., 2003), may
contribute to the ability of S. aureus to adjust a favorable balance
between neutrophil attraction and lysis.
The implication of FPR2/ALX in both severe bacterial infec-
tions and chronic degenerative diseases contributes to the
notion that such virtually unrelated pathological processes may
be more closely connected than previously anticipated (Karin
et al., 2006). Future studies will show in which types of disease
FPR2/ALX is beneficial or may even contribute to exacerbation.
A detailed understanding of FPR2/ALX ligands and conse-
quences of FPR2/ALX activation will help to develop new strate-
gies for interfering with CA-MRSA infection and other major
human diseases.
EXPERIMENTAL PROCEDURES
Synthetic Peptides
PSM peptides with the recently published sequences (Wang et al., 2007;
Queck et al., 2009), the FPR2/ALX-specific control ligand MMK1 (LES
IFRSLLFRVM-NH2) (Fu et al., 2006), and the FPR2/ALX inhibitor WRW4
(WRWWWW-NH2) (Karlsson et al., 2006; Onnheim et al., 2008) were synthe-
sized (EMC Microcollections). PSM-mec was synthesized by American
Peptide Company, Inc. (Sunnyvale, CA). PSMa1 (MGIIAGIIKVIKSLIEQFTGK),
PSMa2 (MGIIAGIIKFIKGLIEKFTGK), PSMa3 (MEFVAKLFKFFKDLLGKFLGNN),
PSMa4 (MAIVGTIIKIIKAIIDIFAK), PSMb1 (MEGLFNAIKDTVTAAINNDGAKLGT
SIVSIVENGVGLLGKLFGF), PSMb2 (MTGLAEAIANTVQAAQQHDSVKLGTSIV
DIANGVGLLGKLFGF), d-toxin (MAQDIISTISDLVKWIIDTVNKFTKK), and PSM-
mec (MDFTGVITSIIDLIKTCIQAFG) were synthesized in their formylated and
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boxytetramethylrhodamin. fMLF was purchased from Sigma. Scrambled
variant of WRW4 with all-D amino acids (wwrwww) and of alpha PSM with retro-
grade amino acid sequence (KAFIDIIAKIIKIITGVIAM) were obtained from EMC
Microcollections.
Bacteria and Cell Lines
USA300 and USA400 or COL, Mu50, and N315 are prevalent CA-MRSA or
HA-MRSA strains, respectively (Diep and Otto, 2008). Defined PSM mutants
have recently been described in detail (Wang et al., 2007). Bacterial culture
supernatants were obtained by centrifugation of overnight cultures grown in
tryptic soy broth (TSB) and filtered through 0.2 mm pore size filters. No chemo-
tactic or stimulatory activity was detected in noninoculated medium at relevant
concentrations.
HL60 cells stably transfected with human FPR1, FPR2/ALX, and FPR3 have
been described recently (Christophe et al., 2001; Dahlgren et al., 2000). These
cells were grown in RPMI medium (Biochrom) supplemented with 10% FCS
(Sigma-Aldrich), 20 mM HEPES (Biochrom), penicillin (100 units/ml), strepto-
mycin (100 mg/ml) (GIBCO), and 1 3 Glutamax (GIBCO). Transfected cells
were grown in the presence of G418 (Biochrom) at a final concentration of
1 mg/ml.
Neutrophil Chemotaxis
Human neutrophils were isolated by standard Ficoll/Histopaque gradient
centrifugation (Du¨rr et al., 2006). Chemotaxis of neutrophils toward staphylo-
coccal supernatants or synthetic peptides was determined by using fluores-
cence-labeled neutrophils that migrated through a 3 mm pore size
polycarbonate trans-well filter, as described recently (Du¨rr et al., 2006).
Synthetic chemoattractants were used at concentrations in the linear range
of the dose-response curves. Initial control experiments were performed to
verify that PSM peptides mobilize neutrophils by chemotactic rather than by
undirected chemokinetic stimulation. Neutrophil migration from the upper to
the lower trans-well chamber was only observed when the peptides were
added to the lower chamber. When an even PSM concentration was present
in the two chambers, no such migration was observed, thereby confirming
that PSMs induce, in fact, chemotactic migration in neutrophils. USA300
culture supernatants were used at 1% dilution. The relative fluorescence
measured was corrected for the buffer control (only buffer added to lower
compartment) and divided through thousand.
Measurement of Calcium Ion Fluxes in Human Neutrophils
and HL60 Cells
Calcium fluxes were monitored in many experiments as a surrogate marker for
chemotaxis because it can be measured more robustly and accurately than
chemotaxis. Calcium fluxes were analyzed by stimulating cells loaded with
Fluo-3-AM (Molecular Probes) and monitoring fluorescence with a FACSCali-
bur flow cytometer (Becton Dickinson) as described recently (de Haas et al.,
2004). For EC50 determination, Ca
2+ flux measurements were carried out at
37C. In order to study the influence of pertussis toxin (PTX), cells were prein-
cubated with 1 mg/ml PTX (List Biological Laboratories) for 3 hr at 37C under
5% CO2. For measuring the influence of CHIPS or FLIPr, 13 10
6 cells/ml were
preincubated with CHIPS or FLIPr at final concentrations of 1.4 mg/ml or
0.5 mg/ml, respectively, for 20 min at room temperature under agitation. The
CHIPS and FLIPr proteins were prepared as described recently (de Haas
et al., 2004; Prat et al., 2006). Synthetic chemoattractants were used at
concentrations in the linear range of the dose-response curves. In order to
stimulate neutrophils, peptides were used at final concentrations of 250 nM,
2 mM for formylated PSMsa3 and b1 or 1 mM for d-toxin and PSM-mec, respec-
tively; 10 mM for nonformylated PSMa3; and 10 nM or 50 nM for fMLF or
MMK1, respectively. HL60 cells were stimulated with final peptide concentra-
tions of 62.5 nM (formylated PSMa3), 125 nM (formylated PSMa2), 250 nM
(formylated d-toxin, PSM-mec), 500 nM (formylated PSMsa1, a4, b1, b2), or
2 mM (all nonformylated PSMs). fMLF and MMK1 were used for HL60 cells
at final concentrations of 20 nM and 10 nM, respectively. USA300 culture
supernatants were used at 0.047% dilution unless otherwise noted. Measure-
ments of 2000 events were performed and calcium flux was expressed as rela-
tive fluorescence corrected for buffer controls.Cell HPeptide Binding and Displacement Assays
105 HL60 cells or 5 3 105 PMN were washed with PBS containing 0.1% HSA
and incubated with increasing concentrations of 5-carboxytetramethylrhoda-
min-labeled peptides for 30 min (neutrophils) or 2 hr (HL60) at 37C under
agitation. Cells were washed twice with ice-cold PBS containing 0.1% HSA,
and cell-associated fluorescence was measured using a FACSCalibur flow cy-
tometer.
For displacement experiments with phycoerythrin-labeled monoclonal
mouse, anti-human FPR2/ALX antibody Clone #304405 (R and D Systems)
FPR2/ALX-transfected HL60 cells were first blocked 15 min at room tempera-
ture with 1% HSA in PBS. Then, 1 3 105 cells were washed with PBS, sedi-
mented by centrifugation, resuspended in PBS containing increasing
concentrations of PSMa2, PSMa3 or d-toxin, and incubated for 15 min at
300 rpm and 37C. Then, either anti-FPR2/ALX antibody or an appropriate iso-
type control (R and D Systems) was added, and cells were incubated for
another 45 min under agitation on ice. After washing with 200 ml PBS,
fluorescence was measured using a FACSCalibur flow cytometer. Control
experiments confirmed that this antibody does not bind to untransfected or
FPR1-transfected HL60 (data not shown).
The radioactively labeled ligand competition assay was performed by MDS
Pharma Services (Taipei, Taiwan) as described recently (Elagoz et al., 2004;
Christophe et al., 2001). In brief, purified membranes of CHO cells transiently
transfected with FPR2/ALX were incubated at room temperature for 90 min
with 0.025 nM of the synthetic 125I-labeled FPR2/ALX ligand WKYMVm in
the absence or presence of increasing concentrations of either formylated
PSMa3 or of the established FPR2/ALX control ligand peptide CKb8-1 (Elagoz
et al., 2004). Unbound tracer was washed, and bound label was counted using
a TopCount microplate scintillation and luminescence counter (PerkinElmer
Life and Analytical Sciences, Waltham, MA).Mouse Experiments
Mouse leukocytes were obtained from the peritoneum of 12-week-old female
CD1 mice (Charles River) upon inducing an intraperitoneal inflammatory reac-
tion by repeated casein injection as described previously (Du¨rr et al., 2006).
Calcium fluxes in mouse neutrophils were determined as described above
for human neutrophils with final concentrations of 250, 12.5, and 50 nM of for-
mylated PSMa3, a2, and d-toxin, respectively, or 500 nM of fMLF and MMK1.
The mouse air pouch model was conducted essentially as described else-
where (Perretti et al., 2002; Devosse et al., 2009). In brief, air pouches were
raised on the dorsum of 6- to 8-week-old female BALB/c mice (Harlan
Winkelmann) by injection of 5 ml (day 1) and 3 ml (day 4) sterile air. The test
peptides were dissolved in DMSO at 100 mM (WRW4 and the scrambled
variant wwrw3) and 10 mM (PSMa2) and then diluted with PBS. On day 7,
250 ml PBS with 0.27 mM WRW4 or wwrw3 (corresponding to ca. 7.5 mg/kg
body weight) or the corresponding amount of DMSO were injected into the
air pouch. After 15 min, the mice received a second injection into the air pouch
of 750 ml PBS with 27 mM PSMa2 or the corresponding amount of DMSO. After
4 hr, the mice were sacrificed, air pouches were rinsed with 2 ml of ice-cold
PBS, and leukocytes were counted.
In the mouse peritonitis model, WRW4 at 7.5 mg/kg body weight or the
vehicle control (2% DMSO) in 300 ml PBS was injected into the peritoneum
of 6- to 8-weeks-old female BALB/c mice. At 20 min later, 300 ml PBS or
PBS containing 23 107 live S. aureus USA300 were intraperitoneally injected.
At 2 hr after infection, the mice were euthanized with CO2. Subsequently, peri-
toneal exudates were collected, and leukocytes were stained and counted as
described previously (Wang et al., 2007). FITC-conjugated antibody to mouse
Gr1+ and a corresponding isotype control were purchased from BD Biosci-
ence. Samples were analyzed on a FACSCalibur flow cytometer. Initial control
experiments showed that application of WRW4 prior to infection had no impact
on numbers of life bacteria after the 2 hr infection period.
Animal experiments were performed according to German law with permis-
sion of the responsible authorities (Regierungspra¨sidium Tu¨bingen).IL-8 Production and Cell Lysis
Human IL-8 was measured using an ELISA kit (R&D Systems) according to the
manufacturer’s instructions. Lysis of neutrophils and HL60 cells by PSM
peptides was determined by measuring the release of cytoplasmic lactateost & Microbe 7, 463–473, June 17, 2010 ª2010 Elsevier Inc. 471
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Human FPR2/ALX Senses PSM-like Bacterial Toxinsdehydrogenase (Cytotoxicity Detection Kit, Roche) as described recently
(Wang et al., 2007).
Statistical Methods
Statistical analyses were performed with the Prism 4.0 package (GraphPad
Software), and the between-group differences were analyzed for significance
with the two-tailed Student’s t test unless otherwise noted.
SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures and can be found with this
article online at doi:10.1016/j.chom.2010.05.012.
ACKNOWLEDGMENTS
We thank Manuela Du¨rr for helpful discussion and Nele Nikola for excellent
technical help. Our research is supported by grants from the German Research
Foundation (SFB685, GRK685, TR34, SFB766, SPP1130); from the German
Ministry of Education and Research (NGFN2, SkinStaph); from the IZKF
program of the Medical Faculty, University of Tu¨bingen, to A.P.; from the Euro-
pean Union (LSHM-CT-2004-512093) to J.A.v.S. and A.P.; from the Intramural
Program of the National Institutes of Allergy and Infectious Diseases, U.S.
National Institutes of Health to M.O.; and from the CEA, the CNRS, and the
University Joseph-Fourier to M.R. and F.B.
Received: December 23, 2009
Revised: April 9, 2010
Accepted: May 10, 2010
Published: June 16, 2010
REFERENCES
Alvarez, V., Coto, E., Setie´n, F., Gonza´lez-Roces, S., and Lo´pez-Larrea, C.
(1996). Molecular evolution of the N-formyl peptide and C5a receptors in
non-human primates. Immunogenetics 44, 446–452.
Bubeck Wardenburg, J., Bae, T., Otto, M., Deleo, F.R., and Schneewind, O.
(2007). Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin
in Staphylococcus aureus pneumonia. Nat. Med. 13, 1405–1406.
Chambers, H.F., and Deleo, F.R. (2009). Waves of resistance: Staphylococcus
aureus in the antibiotic era. Nat. Rev. Microbiol. 7, 629–641.
Christophe, T., Karlsson, A., Dugave, C., Rabiet, M.J., Boulay, F., and
Dahlgren, C. (2001). The synthetic peptide Trp-Lys-Tyr-Met-Val-Met-NH2
specifically activates neutrophils through FPRL1/lipoxin A4 receptors and is
an agonist for the orphan monocyte-expressed chemoattractant receptor
FPRL2. J. Biol. Chem. 276, 21585–21593.
Cui, Y., Le, Y., Yazawa, H., Gong, W., and Wang, J.M. (2002). Potential role
of the formyl peptide receptor-like 1 (FPRL1) in inflammatory aspects of
Alzheimer’s disease. J. Leukoc. Biol. 72, 628–635.
Dahlgren, C., Christophe, T., Boulay, F., Madianos, P.N., Rabiet, M.J., and
Karlsson, A. (2000). The synthetic chemoattractant Trp-Lys-Tyr-Met-Val-
DMet activates neutrophils preferentially through the lipoxin A(4) receptor.
Blood 95, 1810–1818.
de Haas, C.J., Veldkamp, K.E., Peschel, A., Weerkamp, F., Van Wamel, W.J.,
Heezius, E.C., Poppelier, M.J., Van Kessel, K.P., and van Strijp, J.A. (2004).
Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiin-
flammatory agent. J. Exp. Med. 199, 687–695.
Devosse, T., Guillabert, A., D’Haene, N., Berton, A., De Nadai, P., Noel, S.,
Brait, M., Franssen, J.D., Sozzani, S., Salmon, I., and Parmentier, M. (2009).
Formyl peptide receptor-like 2 is expressed and functional in plasmacytoid
dendritic cells, tissue-specific macrophage subpopulations, and eosinophils.
J. Immunol. 182, 4974–4984.
Diep, B.A., and Otto, M. (2008). The role of virulence determinants in commu-
nity-associated MRSA pathogenesis. Trends Microbiol. 16, 361–369.
Diep, B.A., Palazzolo-Ballance, A.M., Tattevin, P., Basuino, L., Braughton,
K.R., Whitney, A.R., Chen, L., Kreiswirth, B.N., Otto, M., DeLeo, F.R., and
Chambers, H.F. (2008). Contribution of Panton-Valentine leukocidin in472 Cell Host & Microbe 7, 463–473, June 17, 2010 ª2010 Elsevier Incommunity-associated methicillin-resistant Staphylococcus aureus patho-
genesis. PLoS ONE 3, e3198.
Du¨rr, M.C., Kristian, S.A., Otto, M., Matteoli, G., Margolis, P.S., Trias, J., van
Kessel, K.P., van Strijp, J.A., Bohn, E., Landmann, R., and Peschel, A.
(2006). Neutrophil chemotaxis by pathogen-associated molecular patterns—
formylated peptides are crucial but not the sole neutrophil attractants
produced by Staphylococcus aureus. Cell. Microbiol. 8, 207–217.
Elagoz, A., Henderson, D., Babu, P.S., Salter, S., Grahames, C., Bowers, L.,
Roy, M.O., Laplante, P., Grazzini, E., Ahmad, S., and Lembo, P.M. (2004).
A truncated form of CKbeta8-1 is a potent agonist for human formyl
peptide-receptor-like 1 receptor. Br. J. Pharmacol. 141, 37–46.
Foster, T.J. (2004). The Staphylococcus aureus ‘‘superbug’’. J. Clin. Invest.
114, 1693–1696.
Fu, H., Karlsson, J., Bylund, J., Movitz, C., Karlsson, A., and Dahlgren, C.
(2006). Ligand recognition and activation of formyl peptide receptors in neutro-
phils. J. Leukoc. Biol. 79, 247–256.
Gao, J.L., Chen, H., Filie, J.D., Kozak, C.A., and Murphy, P.M. (1998). Differen-
tial expansion of the N-formylpeptide receptor gene cluster in human and
mouse. Genomics 51, 270–276.
Hartt, J.K., Barish, G., Murphy, P.M., and Gao, J.L. (1999). N-formylpeptides
induce two distinct concentration optima for mouse neutrophil chemotaxis
by differential interaction with two N-formylpeptide receptor (FPR) subtypes.
Molecular characterization of FPR2, a second mouse neutrophil FPR. J.
Exp. Med. 190, 741–747.
Hecht, I., Rong, J., Sampaio, A.L., Hermesh, C., Rutledge, C., Shemesh, R.,
Toporik, A., Beiman, M., Dassa, L., Niv, H., et al. (2009). A novel peptide
agonist of formyl-peptide receptor-like 1 (ALX) displays anti-inflammatory
and cardioprotective effects. J. Pharmacol. Exp. Ther. 328, 426–434.
Kahl, B.C., and Peters, G. (2007). Microbiology. Mayhem in the lung. Science
315, 1082–1083.
Kalmar, J.R., and Van Dyke, T.E. (1994). Effect of bacterial products on neutro-
phil chemotaxis. Methods Enzymol. 236, 58–87.
Karin, M., Lawrence, T., and Nizet, V. (2006). Innate immunity gone awry: link-
ing microbial infections to chronic inflammation and cancer. Cell 124, 823–835.
Karlsson, J., Fu, H., Boulay, F., Bylund, J., and Dahlgren, C. (2006). The
peptide Trp-Lys-Tyr-Met-Val-D-Met activates neutrophils through the formyl
peptide receptor only when signaling through the formylpeptide receptor like
1 is blocked. A receptor switch with implications for signal transduction studies
with inhibitors and receptor antagonists. Biochem. Pharmacol. 71, 1488–1496.
Le, Y., Murphy, P.M., and Wang, J.M. (2002). Formyl-peptide receptors revis-
ited. Trends Immunol. 23, 541–548.
Leulier, F., and Lemaitre, B. (2008). Toll-like receptors—taking an evolutionary
approach. Nat. Rev. Genet. 9, 165–178.
Mader, D., Rabiet, M.J., Boulay, F., and Peschel, A. (2010). Formyl peptide
receptor-mediated proinflammatory consequences of peptide deformylase
inhibition in Staphylococcus aureus. Microbes Infect. 12, 415–419.
Migeotte, I., Riboldi, E., Franssen, J.D., Gre´goire, F., Loison, C., Wittamer, V.,
Detheux, M., Robberecht, P., Costagliola, S., Vassart, G., et al. (2005). Identi-
fication and characterization of an endogenous chemotactic ligand specific for
FPRL2. J. Exp. Med. 201, 83–93.
Migeotte, I., Communi, D., and Parmentier, M. (2006). Formyl peptide recep-
tors: a promiscuous subfamily of G protein-coupled receptors controlling
immune responses. Cytokine Growth Factor Rev. 17, 501–519.
Murphy, P.M., Ozc¸elik, T., Kenney, R.T., Tiffany, H.L., McDermott, D., and
Francke, U. (1992). A structural homologue of the N-formyl peptide receptor.
Characterization and chromosome mapping of a peptide chemoattractant
receptor family. J. Biol. Chem. 267, 7637–7643.
Onnheim, K., Bylund, J., Boulay, F., Dahlgren, C., and Forsman, H. (2008).
Tumour necrosis factor (TNF)-alpha primes murine neutrophils when triggered
via formyl peptide receptor-related sequence 2, the murine orthologue of
human formyl peptide receptor-like 1, through a process involving the type I
TNF receptor and subcellular granule mobilization. Immunology 125, 591–600.
Palazzolo-Ballance, A.M., Reniere, M.L., Braughton, K.R., Sturdevant, D.E.,
Otto, M., Kreiswirth, B.N., Skaar, E.P., and DeLeo, F.R. (2008). Neutrophilc.
Cell Host & Microbe
Human FPR2/ALX Senses PSM-like Bacterial Toxinsmicrobicides induce a pathogen survival response in community-associated
methicillin-resistant Staphylococcus aureus. J. Immunol. 180, 500–509.
Perretti, M., Chiang, N., La, M., Fierro, I.M., Marullo, S., Getting, S.J., Solito, E.,
and Serhan, C.N. (2002). Endogenous lipid- and peptide-derived anti-inflam-
matory pathways generated with glucocorticoid and aspirin treatment activate
the lipoxin A4 receptor. Nat. Med. 8, 1296–1302.
Prat, C., Bestebroer, J., de Haas, C.J., van Strijp, J.A., and van Kessel, K.P.
(2006). A new staphylococcal anti-inflammatory protein that antagonizes the
formyl peptide receptor-like 1. J. Immunol. 177, 8017–8026.
Queck, S.Y., Jameson-Lee, M., Villaruz, A.E., Bach, T.H., Khan, B.A., Sturde-
vant, D.E., Ricklefs, S.M., Li, M., and Otto, M. (2008). RNAIII-independent
target gene control by the agr quorum-sensing system: insight into the evolu-
tion of virulence regulation in Staphylococcus aureus. Mol. Cell 32, 150–158.
Queck, S.Y., Khan, B.A., Wang, R., Bach, T.H., Kretschmer, D., Chen, L.,
Kreiswirth, B.N., Peschel, A., Deleo, F.R., and Otto, M. (2009). Mobile genetic
element-encoded cytolysin connects virulence to methicillin resistance in
MRSA. PLoS Pathog. 5, e1000533.
Saı¨d-Salim, B., Mathema, B., and Kreiswirth, B.N. (2003). Community-
acquired methicillin-resistant Staphylococcus aureus: an emerging pathogen.
Infect. Control Hosp. Epidemiol. 24, 451–455.
Shopsin, B., Drlica-Wagner, A., Mathema, B., Adhikari, R.P., Kreiswirth, B.N.,
and Novick, R.P. (2008). Prevalence of agr dysfunction among colonizing
Staphylococcus aureus strains. J. Infect. Dis. 198, 1171–1174.Cell HSomerville, G.A., Cockayne, A., Du¨rr, M., Peschel, A., Otto, M., and Musser,
J.M. (2003). Synthesis and deformylation of Staphylococcus aureus delta-
toxin are linked to tricarboxylic acid cycle activity. J. Bacteriol. 185,
6686–6694.
Southgate, E.L., He, R.L., Gao, J.L., Murphy, P.M., Nanamori, M., and Ye, R.D.
(2008). Identification of formyl peptides from Listeria monocytogenes and
Staphylococcus aureus as potent chemoattractants for mouse neutrophils.
J. Immunol. 181, 1429–1437.
Styrt, B. (1989). Species variation in neutrophil biochemistry and function.
J. Leukoc. Biol. 46, 63–74.
Su, S.B., Gong, W., Gao, J.L., Shen, W., Murphy, P.M., Oppenheim, J.J., and
Wang, J.M. (1999). A seven-transmembrane, G protein-coupled receptor,
FPRL1, mediates the chemotactic activity of serum amyloid A for human
phagocytic cells. J. Exp. Med. 189, 395–402.
Uematsu, S., and Akira, S. (2006). Toll-like receptors and innate immunity.
J. Mol. Med. 84, 712–725.
Wang, R., Braughton, K.R., Kretschmer, D., Bach, T.H., Queck, S.Y., Li, M.,
Kennedy, A.D., Dorward, D.W., Klebanoff, S.J., Peschel, A., et al. (2007). Iden-
tification of novel cytolytic peptides as key virulence determinants for commu-
nity-associated MRSA. Nat. Med. 13, 1510–1514.
Ye, R.D., Boulay, F., Wang, J.M., Dahlgren, C., Gerard, C., Parmentier, M.,
Serhan, C.N., and Murphy, P.M. (2009). International Union of Basic and Clin-
ical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR)
family. Pharmacol. Rev. 61, 119–161.ost & Microbe 7, 463–473, June 17, 2010 ª2010 Elsevier Inc. 473
